Ads
related to: sloan kettering cancer centermskcc.org has been visited by 100K+ users in the past month
Search results
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
FierceBiotech· 18 hours agoResearchers at the National Institutes of Health and Memorial Sloan Kettering Cancer Center said...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 17 hours agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial ...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 18 hours agoA study of 75 women with breast cancer by researchers from the Memorial Sloan Kettering Cancer Centre in New York ...
Scientists develop AI tool to predict how cancer patients will respond to immunotherapy
Medical Xpress· 2 days agoNCI is part of the National Institutes of Health. Currently, two predictive biomarkers are approved by the Food and Drug ...
Opinion: The Fauci witch hunt intensifies while the next threat looms
CNN via AOL· 11 hours agoRather than hold an after-action review to glean lessons learned from the Covid-19 pandemic to...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 1 day agoThe drug candidate was found to be 100% effective in treating all patients who were enrolled in the...
Newswise Expert | Yuanyuan Zhang, UT Southwestern Medical Center
Newswise· 9 hours agoDr. Zhang earned her medical and doctorate degrees from UT Southwestern. Following graduation, she completed an internship with Memorial Sloan-Kettering ...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
NIH AI tool predicts cancer patients’ immunotherapy outcomes
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe proof-of-concept study was spearheaded by the Center for Cancer Research at the National Cancer...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 2 days agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...